BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12705494)

  • 1. Biochemical and molecular studies in 26 Spanish patients with congenital disorder of glycosylation type Ia.
    Briones P; Vilaseca MA; Schollen E; Ferrer I; Maties M; Busquets C; Artuch R; Gort L; Marco M; van Schaftingen E; Matthijs G; Jaeken J; Chabás A
    J Inherit Metab Dis; 2002 Dec; 25(8):635-46. PubMed ID: 12705494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis revealing destabilizing mutations in phosphomannomutase 2 deficiency (PMM2-CDG): expression analysis of PMM2-CDG mutations.
    Vega AI; Pérez-Cerdá C; Abia D; Gámez A; Briones P; Artuch R; Desviat LR; Ugarte M; Pérez B
    J Inherit Metab Dis; 2011 Aug; 34(4):929-39. PubMed ID: 21541725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of PMM2-CDG-Causing Mutations on the Folding, Activity, and Stability of the PMM2 Protein.
    Yuste-Checa P; Gámez A; Brasil S; Desviat LR; Ugarte M; Pérez-Cerdá C; Pérez B
    Hum Mutat; 2015 Sep; 36(9):851-60. PubMed ID: 26014514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.
    Quelhas D; Quental R; Vilarinho L; Amorim A; Azevedo L
    Ann Hum Genet; 2007 May; 71(Pt 3):348-53. PubMed ID: 17166182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular landscape of phosphomannose mutase deficiency in iberian peninsula: identification of 15 population-specific mutations.
    Pérez B; Briones P; Quelhas D; Artuch R; Vega AI; Quintana E; Gort L; Ecay MJ; Matthijs G; Ugarte M; Pérez-Cerdá C
    JIMD Rep; 2011; 1():117-23. PubMed ID: 23430838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of four novel PMM2 mutations in congenital disorders of glycosylation (CDG) Ia French patients.
    Vuillaumier-Barrot S; Hetet G; Barnier A; Dupré T; Cuer M; de Lonlay P; Cormier-Daire V; Durand G; Grandchamp B; Seta N
    J Med Genet; 2000 Aug; 37(8):579-80. PubMed ID: 10922383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency.
    Westphal V; Kjaergaard S; Schollen E; Martens K; Grunewald S; Schwartz M; Matthijs G; Freeze HH
    Hum Mol Genet; 2002 Mar; 11(5):599-604. PubMed ID: 11875054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new insight into PMM2 mutations in the French population.
    Le Bizec C; Vuillaumier-Barrot S; Barnier A; Dupré T; Durand G; Seta N
    Hum Mutat; 2005 May; 25(5):504-5. PubMed ID: 15844218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of congenital disorder of glycosylation type Ia (CDG-Ia) by cordocentesis and transferrin isoelectric focussing of serum of a 27-week fetus with non-immune hydrops.
    Edwards M; McKenzie F; O'callaghan S; Somerset D; Woodford P; Spilsbury J; Fietz M; Fletcher J
    Prenat Diagn; 2006 Oct; 26(10):985-8. PubMed ID: 16915591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital disorders of glycosylation (CDG) may be underdiagnosed when mimicking mitochondrial disease.
    Briones P; Vilaseca MA; García-Silva MT; Pineda M; Colomer J; Ferrer I; Artigas J; Jaeken J; Chabás A
    Eur J Paediatr Neurol; 2001; 5(3):127-31. PubMed ID: 11589167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild clinical and biochemical phenotype in two patients with PMM2-CDG (congenital disorder of glycosylation Ia).
    Casado M; O'Callaghan MM; Montero R; Pérez-Cerda C; Pérez B; Briones P; Quintana E; Muchart J; Aracil A; Pineda M; Artuch R
    Cerebellum; 2012 Jun; 11(2):557-63. PubMed ID: 22012410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations.
    Erlandson A; Bjursell C; Stibler H; Kristiansson B; Wahlström J; Martinsson T
    Hum Genet; 2001 May; 108(5):359-67. PubMed ID: 11409861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).
    Schollen E; Kjaergaard S; Legius E; Schwartz M; Matthijs G
    Eur J Hum Genet; 2000 May; 8(5):367-71. PubMed ID: 10854097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital disorder of glycosylation type Ia in a 6-year-old girl with a mild intellectual phenotype: two novel PMM2 mutations.
    Coman D; Klingberg S; Morris D; McGill J; Mercer H
    J Inherit Metab Dis; 2005; 28(6):1189-90. PubMed ID: 16435227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital disorder of glycosylation type Ia presenting with hydrops fetalis.
    van de Kamp JM; Lefeber DJ; Ruijter GJ; Steggerda SJ; den Hollander NS; Willems SM; Matthijs G; Poorthuis BJ; Wevers RA
    J Med Genet; 2007 Apr; 44(4):277-80. PubMed ID: 17158594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation.
    Lao JP; DiPrimio N; Prangley M; Sam FS; Mast JD; Perlstein EO
    G3 (Bethesda); 2019 Feb; 9(2):413-423. PubMed ID: 30530630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of three splicing mutations identified in the PMM2 gene: toward a new therapy for congenital disorder of glycosylation type Ia.
    Vega AI; Pérez-Cerdá C; Desviat LR; Matthijs G; Ugarte M; Pérez B
    Hum Mutat; 2009 May; 30(5):795-803. PubMed ID: 19235233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphomannomutase activity in congenital disorders of glycosylation type Ia determined by direct analysis of the interconversion of mannose-1-phosphate to mannose-6-phosphate by high-pH anion-exchange chromatography with pulsed amperometric detection.
    Orvisky E; Stubblefield B; Long RT; Martin BM; Sidransky E; Krasnewich D
    Anal Biochem; 2003 Jun; 317(1):12-8. PubMed ID: 12729595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype).
    Barone R; Sturiale L; Fiumara A; Uziel G; Garozzo D; Jaeken J
    J Inherit Metab Dis; 2007 Feb; 30(1):107. PubMed ID: 17186415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening using serum percentage of carbohydrate-deficient transferrin for congenital disorders of glycosylation in children with suspected metabolic disease.
    Pérez-Cerdá C; Quelhas D; Vega AI; Ecay J; Vilarinho L; Ugarte M
    Clin Chem; 2008 Jan; 54(1):93-100. PubMed ID: 18024528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.